Ofatumumab-associated acute respiratory manifestations: clinical characteristics and treatment.
作者信息
Bonanni Alice, Bertelli Enrica, Moscatelli Andrea, Lampugnani Elisabetta, Bodria Monica, Ravani Pietro, Ghiggeri Gian Marco
机构信息
Division of Nephrology, Dialysis, Transplantation, Giannina Gaslini Children's Hospital, Genoa, 16148, Italy.
Neonatal and Pediatric ICU, Dept. of Critical Care and Perinatal Medicine, Giannina Gaslini Children's Hospital, Genoa, 16148, Italy.
出版信息
Br J Clin Pharmacol. 2016 Oct;82(4):1146-8. doi: 10.1111/bcp.13029. Epub 2016 Jun 28.
Abstract
摘要
相似文献
1
Ofatumumab-associated acute respiratory manifestations: clinical characteristics and treatment.奥法木单抗相关的急性呼吸道表现：临床特征与治疗
Br J Clin Pharmacol. 2016 Oct;82(4):1146-8. doi: 10.1111/bcp.13029. Epub 2016 Jun 28.
2
Effect of Albuterol Premedication vs Placebo on the Occurrence of Respiratory Adverse Events in Children Undergoing Tonsillectomies: The REACT Randomized Clinical Trial.沙丁胺醇用药预防与安慰剂对照在扁桃体切除术患儿中发生呼吸不良事件的效果：REACT 随机临床试验。
JAMA Pediatr. 2019 Jun 1;173(6):527-533. doi: 10.1001/jamapediatrics.2019.0788.
3
Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol.在依赖类固醇和钙调神经磷酸酶抑制剂的儿童特发性肾病综合征中比较奥法木单抗与利妥昔单抗的随机对照试验：研究方案
BMJ Open. 2017 Mar 17;7(3):e013319. doi: 10.1136/bmjopen-2016-013319.
4
Ofatumumab in two pediatric nephrotic syndrome patients allergic to rituximab.奥法木单抗用于两名对利妥昔单抗过敏的儿童肾病综合征患者。
Pediatr Nephrol. 2017 Jan;32(1):181-184. doi: 10.1007/s00467-016-3498-y. Epub 2016 Sep 29.
5
Ofatumumab for rituximab-resistant nephrotic syndrome.奥法木单抗用于治疗利妥昔单抗耐药的肾病综合征。
N Engl J Med. 2014 Mar 27;370(13):1268-70. doi: 10.1056/NEJMc1308488.
6
Ofatumumab for the treatment of childhood nephrotic syndrome.奥法妥木单抗用于治疗儿童肾病综合征。
Pediatr Nephrol. 2017 May;32(5):835-841. doi: 10.1007/s00467-017-3621-8. Epub 2017 Feb 17.
7
Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemia.奥法妥木单抗治疗新诊断和复发/难治性慢性淋巴细胞白血病。
Expert Rev Anticancer Ther. 2011 Feb;11(2):151-60. doi: 10.1586/era.10.223.
8
Ofatumumab in post-transplantation recurrence of a pediatric steroid-resistant idiopathic nephrotic syndrome.奥法妥木单抗用于小儿激素抵抗型特发性肾病综合征移植后复发的治疗
Pediatr Transplant. 2018 Jun;22(4):e13175. doi: 10.1111/petr.13175. Epub 2018 Mar 23.
9
Trichomegaly of the eyelashes following treatment with cetuximab.西妥昔单抗治疗后出现的睫毛粗长症。
Ann Oncol. 2005 Oct;16(10):1711-2. doi: 10.1093/annonc/mdi300. Epub 2005 Jun 21.
10
Chest physiotherapy for acute wheezing: an inappropriate protocol in a misdiagnosed group of patients.急性喘息的胸部物理治疗：在一组误诊患者中采用的不恰当方案。
Acta Paediatr. 2014 Aug;103(8):e325-6. doi: 10.1111/apa.12652. Epub 2014 Apr 29.
引用本文的文献
1
Targeting CD20 for B-cell Depletion in Autoimmune Kidney Disease: Next Generation.针对自身免疫性肾脏疾病中B细胞耗竭的CD20靶向治疗：新一代疗法
BioDrugs. 2025 Sep 8. doi: 10.1007/s40259-025-00742-0.
2
New and Old Anti-CD20 Monoclonal Antibodies for Nephrotic Syndrome. Where We Are?新型及旧型抗 CD20 单克隆抗体治疗肾病综合征：我们已走到哪一步？
Front Immunol. 2022 Feb 11;13:805697. doi: 10.3389/fimmu.2022.805697. eCollection 2022.
3
Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome.抗 CD20 嵌合型和人源化抗体在儿童特发性肾病综合征中的应用与不良反应的相关性。
Br J Clin Pharmacol. 2018 Jun;84(6):1238-1249. doi: 10.1111/bcp.13548. Epub 2018 Mar 25.
4
Ofatumumab-associated acute pneumonitis: Not new but still the first case.奥法木单抗相关的急性肺炎：并非新病例，但仍是首例。
Pharmacol Res Perspect. 2016 Dec 26;5(1):e00267. doi: 10.1002/prp2.267. eCollection 2017 Feb.
5
Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol.在依赖类固醇和钙调神经磷酸酶抑制剂的儿童特发性肾病综合征中比较奥法木单抗与利妥昔单抗的随机对照试验：研究方案
BMJ Open. 2017 Mar 17;7(3):e013319. doi: 10.1136/bmjopen-2016-013319.
本文引用的文献
1
Low-dose ofatumumab for rituximab-resistant nephrotic syndrome.低剂量奥法妥木单抗治疗利妥昔单抗耐药的肾病综合征
BMJ Case Rep. 2015 Sep 16;2015:bcr2015210208. doi: 10.1136/bcr-2015-210208.
2
Regulatory T cells and minimal change nephropathy: in the midst of a complex network.调节性T细胞与微小病变肾病：处于复杂网络之中
Clin Exp Immunol. 2016 Feb;183(2):166-74. doi: 10.1111/cei.12675. Epub 2015 Oct 12.
3
Ofatumumab for rituximab-resistant nephrotic syndrome.奥法木单抗用于治疗利妥昔单抗耐药的肾病综合征。
N Engl J Med. 2014 Mar 27;370(13):1268-70. doi: 10.1056/NEJMc1308488.
4
Ofatumumab monotherapy in relapsed/refractory mantle cell lymphoma--a phase II trial.奥法木单抗单药治疗复发/难治性套细胞淋巴瘤——一项II期试验
Br J Haematol. 2014 May;165(4):575-8. doi: 10.1111/bjh.12769. Epub 2014 Feb 8.
5
Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: a phase 2 study.奥法妥木单抗治疗复发缓解型多发性硬化症的安全性和疗效：一项 2 期研究。
Neurology. 2014 Feb 18;82(7):573-81. doi: 10.1212/WNL.0000000000000125. Epub 2014 Jan 22.
6
Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trial.奥法妥木单抗，一种全人源抗 CD20 单克隆抗体，在对甲氨蝶呤应答不足的生物初治、类风湿关节炎患者中的疗效：一项随机、双盲、安慰剂对照临床试验。
Ann Rheum Dis. 2011 Dec;70(12):2119-25. doi: 10.1136/ard.2011.151522. Epub 2011 Aug 22.
7
Structure of the Fab fragment of therapeutic antibody Ofatumumab provides insights into the recognition mechanism with CD20.治疗性抗体奥法木单抗Fab片段的结构为了解其与CD20的识别机制提供了线索。
Mol Immunol. 2009 Jul;46(11-12):2419-23. doi: 10.1016/j.molimm.2009.04.009. Epub 2009 May 8.
Zotero 插件